report adj ep exclud cytosport sale
estim consensu estim report ep includ
ep gain due sale cytosport busi overal result weak sale
weaker expect profit lower estim
back higher input cost plant start-up expens today file
updat earn model reiter ew rate price target
posit side quarter groceri product post better-than-expect
result segment profit grow twice expect aid healthi
volum growth margin
neg side segment post weak result mostli intern
segment post yoy lower segment profit back two voluntari
product recal higher-than-expect plant start-up expens higher feed cost
outlook updat compani updat ep guidanc
alreadi account cent benefit cytosport sale
back higher input cost expectedli volatil domest pork
price amid asf short-term lag pass price reinvest
jot ep estim guid sale also revis downward
sale estim effect tax rate
updat
major risk ew rate includ higher commod price could bring
pressur hormel margin increas competit hormel differ product
categori product recal lawsuit reput concern fx condit
hormel foreign oper custom purchas power risk
quarterli annual ep usd
return equiti ttm
link barclay live interact chart
consensu number refinitiv receiv gmt
barclay capit inc and/or one affili seek busi
compani cover research report result investor awar
firm may conflict interest could affect object report investor
consid report singl factor make invest decis
research report prepar whole part equiti research analyst
base outsid us registered/qualifi research analyst finra
margin return data
balanc sheet cash flow mn
equival
short long-term debt
chang work capit
flow oper
equal weight hormel well establish food
product compani pioneer pork meat
industri offer geograph diversif given
intern presenc across america asia
europ howev valuat longer attract
current headwind expect continu
short-to-medium term
upsid case assum long-term ebit
margin compar base case ebit margin
margin compar base case ebit margin
report adj ep exclud cytosport sale slightli
estim slightli consensu report ep includ
ep gain due sale cytosport busi overal result weak
african swine fever take toll cost net sale grew yoy
weaker expect mostli impact sale contract
segment term profit ebit ebitda margin averag higher
yoy lower estim nonetheless lower-than-expect tax rate due
impact tax gain cytosport divestitur compani file today
updat model reiter ew rate price target
groceri product post better-than-expect result segment profit grew
yoy expect aid healthi volum growth margin across differ
segment post weak result except groceri product
double-digit declin commod sale offset growth brand value-ad
product declin commod profit capac expans expens impact
profit jot busi perform even wors former
post lower yoy segment profit despit flattish sale back impact
two voluntari product recal higher-than-expect plant start-up expens
higher feed cost latter impact tariff fresh pork export higher
manag provid call updat outlook well comment
result highlight call
foodservic sale grow solidli mid-single-digit compani
continu grow value-ad product mix busi becom
declin commod sale refriger food segment partial driven
compani effort focu value-ad product
compani estim hog impact china
entir product quarter compani alreadi seen
price increas expect continu grow storag get lower moreov
manag expect input cost pressur could partial off-set price
updat guidanc reflect higher forecast input cost lag sale price increas
across brand value-ad product well reinvest jot brand
chang estimates/valuation/risk
chang estim increas price
updat model result slightli decreas top-
line estim term profit lower ebit
ebitda estim expect margin pressur due higher input cost lag price
pass reinvest jot updat model leav price
target ew rate unchang
chang estim mn except ep
usd mn
chang
chang
deriv price target base dcf calcul assum wacc
termin growth rate wacc calcul assumpt hormel
continu net cash posit ke base equiti risk
beta tax rate chang prior level given
price target share would trade price-to-earnings slightli
year averag view justifi base healthi
exposur valu ad product relat short term pressur turkey
busi downsid case assum long-term ebit margin base-cas
scenario ebit margin upsid case margin
risk identifi higher commod price could bring pressur hormel
margin increas competit hormel differ product categori product
recal lawsuit reput concern advers fx condit hormel foreign
oper custom purchas power risk
benjamin theurer herebi certifi view express research report accur reflect person view
subject secur issuer refer research report part compens directli indirectli
relat specif recommend view express research report
